Green Cross Medical Science Corporation (KOSDAQ:142280)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,065.00
-10.00 (-0.25%)
At close: Dec 5, 2025
16.98%
Market Cap 88.38B
Revenue (ttm) 111.12B
Net Income (ttm) 5.66B
Shares Out 21.74M
EPS (ttm) 149.25
PE Ratio 27.24
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,724
Average Volume 103,558
Open 4,095.00
Previous Close 4,075.00
Day's Range 4,010.00 - 4,095.00
52-Week Range 3,090.00 - 5,150.00
Beta 0.55
RSI 47.21
Earnings Date Nov 14, 2025

About KOSDAQ:142280

Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1972
Employees 122
Stock Exchange KOSDAQ
Ticker Symbol 142280
Full Company Profile

Financial Performance

In 2024, KOSDAQ:142280's revenue was 103.85 billion, an increase of 10.47% compared to the previous year's 94.01 billion. Earnings were 3.58 billion, an increase of 99.25%.

Financial Statements

News

There is no news available yet.